What is Northern Leaf?
Founded in 2019 and headquartered in Jersey, Northern Leaf operates as a specialized cultivator of medical cannabis. The company occupies a critical niche in the pharmaceutical supply chain, focusing on the production of high-quality, standardized cannabis products for medical applications. By leveraging its strategic location and adherence to stringent cultivation standards, Northern Leaf has established itself as a key player in the European medical cannabis market, bridging the gap between agricultural production and pharmaceutical-grade distribution.
How much funding has Northern Leaf raised?
Northern Leaf has raised a total of $19.3M across 1 funding round:
Other Financing Round
$19.3M
Other Financing Round (2021): $19.3M, investors not publicly disclosed
Key Investors in Northern Leaf
Northern Leaf
Undisclosed investor participating in the funding round.
What's next for Northern Leaf?
Looking ahead, the infusion of capital is expected to accelerate Northern Leaf's infrastructure development and market expansion efforts. As the company transitions into a more mature phase of its lifecycle, the focus will likely shift toward optimizing cultivation yields, enhancing research and development capabilities, and securing additional distribution partnerships across international markets. The strategic deployment of these funds will be essential for maintaining a competitive edge in an industry characterized by rapid regulatory evolution and increasing demand for reliable, medical-grade cannabis solutions.
See full Northern Leaf company page
